Development strategy and business support for an early-stage oncology company

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...
Learn More

Business planning & Monte Carlo simulations for cancer immunotherapy start-up

Challenge An established cancer immunotherapy company needed help with a business plan and valuation for a new company to be setup in collaboration with a major US cancer center
Learn More

Screening for rare disease licensing opportunities

Challenge Our client, a commercial stage biotech company focused on rare and ultra-rare diseases was seeking to build its pipeline of development products. Whilst it had an established business...
Learn More

Searching and assessing stem cell medicines

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....
Learn More

Providing search and assessment support for oncology projects

Challenge A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Searching for late stage therapeutics, devices and diagnostics acquisition targets in the US

Challenge A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was...
Learn More

Scouting medtech technology for M&A opportunities

Challenge A rapidly growing European-headquartered specialty medtech company wanted to conduct a search for M&A opportunities in the interventional medicine arena.
Learn More

Scouting for early-stage oncology opportunities

Challenge A listed North American company needed support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

BLA submission support for a novel antibody-based therapeutic

Challenge Our client was nearing the completion of a pivotal Phase III trial with a novel antibody-based therapeutic. The product was designed to delay recurrence in cancer patients with minimum...
Learn More

Regulatory due diligence

Challenge A clinical stage biopharmaceutical specialist needed support with its regulatory due diligence activities.
Learn More

Supporting medical device 510(k) submissions

Challenge A company had successfully CE marked a novel lung function device, and the next step in the commercial strategy was to obtain 510(k) clearance to market in the USA.
Learn More

Submitting 510(k) applications

Challenge A medical device client needed help securing 510(k) clearance for a non-contact respiratory measurement device.
Learn More